Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-02-16FDA Approved: IRBESARTAN — Supplemental Application (Hisun Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for IRBESARTAN from Hisun Pharmaceuticals USA Inc., approving changes to the generic product's a…
-
CLINICAL_TRIALS trial_result · 2024-02-13Clinical Trial Update: Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension [Phase 4]
Phase 4 clinical trial update on a personalised electronic record support for optimizing hypertension management.
-
FDA approval · 2024-02-05FDA Approved: NEBIVOLOL — Supplemental Application (Modavar Pharmaceuticals LLC)
The FDA approved Modavar Pharmaceuticals LLC's supplemental application for Nebivolol, updating the approval status of an existing Nebivolol…
-
FDA approval · 2024-02-05FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Viona Pharmaceuticals Inc)
FDA approved a supplemental application for Bisoprolol Fumarate and Hydrochlorothiazide from Viona Pharmaceuticals, enabling a new generic c…
-
FDA approval · 2024-02-05FDA Approved: NADOLOL — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Nadolol submitted by Zydus Pharmaceuticals USA Inc., resulting in updated labeling and/or indica…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-02Clinical Trial Update: Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome [EARLY_Phase 1]
Early-phase trial update describing mechanisms of hypertension in women with polycystic ovary syndrome; study terminated with results posted…
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Nashville - Hypertension Management Model [NA]
Clinical trial update for a hypertension management model study completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-22Clinical Trial Update: Communicating Health Information and Improving Coordination With Primary Care [NA]
Clinical trial update related to communicating health information and improving coordination with primary care; study completed with posted …
-
FDA approval · 2024-01-22FDA Approved: VALSARTAN — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application from Unichem Pharmaceuticals (USA), Inc. for valsartan (generic valsartan) under an ANDA.
-
FDA approval · 2024-01-19FDA Approved: TERAZOSIN — Supplemental Application (Bionpharma Inc.)
The FDA approved a supplemental application for Terazosin from Bionpharma Inc., marking an update to the product's approval.
-
CLINICAL_TRIALS trial_result · 2024-01-19Clinical Trial Update: Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension [Phase 2]
Phase 2 trial update evaluating SPC1001 with monotherapy for essential hypertension; study completed.
-
FDA approval · 2024-01-18FDA Approved: BISOPROLOL FUMARATE — Original Application (Harman Finochem Limited)
FDA approved Harman Finochem Limited's bisoprolol fumarate as an original generic application (ANDA). Bisoprolol fumarate is a beta-blocker …
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Effects and Safety of Clonidine Patch on Young and Middle-aged Smokers With Mild Hypertension [Phase 4]
A Phase 4 clinical trial evaluating the effects and safety of a clonidine patch in young and middle-aged smokers with mild hypertension.
-
FDA approval · 2024-01-16FDA Approved: EDARBI — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for EDARBI (azilsartan medoxomil) submitted by Azurity Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease
A terminated clinical trial exploring mechanisms and predictors of hypertension and cardiovascular disease associated with VEGF receptor inh…
-
FDA approval · 2024-01-10FDA Approved: PERINDOPRIL ERBUMINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Perindopril Erbumine from Aurobindo Pharma Limited.
-
FDA approval · 2024-01-10FDA Approved: DOXAZOSIN MESYLATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the generic doxazosin mesylate from Unichem Pharmaceuticals (USA), Inc. under an Original Abbreviated New Drug Application, for…
-
FDA approval · 2024-01-08FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Chartwell RX, LLC)
FDA approves a supplemental application for Triamterene and Hydrochlorothiazide submitted by Chartwell RX, LLC.
-
FDA approval · 2024-01-08FDA Approved: ENALAPRIL MALEATE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for enalapril maleate from Aurobindo Pharma Limited, a generic version of enalapril for cardiovascular…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension [Phase 2]
Phase 2 trial assessing MLS-101 for uncontrolled hypertension with renal involvement completed; results posted.
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Hypertension In Postpartum Preeclampsia Study [NA]
Completed clinical trial on hypertension in postpartum preeclampsia; results posted in 2024.
-
FDA approval · 2024-01-03FDA Approved: PRAZOSIN — Original Application (Lannett Company, Inc.)
The FDA approved Lannett Company's original application for a generic prazosin product, a medication used to treat hypertension.
-
FDA label_change · 2023-12-28FDA Approved: NEBIVOLOL — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA lists a Camber Pharmaceuticals supplemental application for Nebivolol, indicating a label update under the ANDA for Nebivolol.
-
CLINICAL_TRIALS trial_result · 2023-12-28Clinical Trial Update: Personalizing Intervention to Reduce Clinical Inertia in the Treatment of Hypertension [NA]
A completed study evaluating a personalized intervention to reduce clinical inertia in hypertension treatment has its results posted. The tr…
-
CLINICAL_TRIALS trial_result · 2023-12-28Clinical Trial Update: Management of Hypertension in the Early Postpartum: a Randomized Controlled Trial [Phase 4]
A Phase 4 randomized trial evaluating management of hypertension in the early postpartum period for pregnancy-induced hypertension and postp…